Briefing
Care insights for commercial teams
The earliest months of a therapy launch often determine its long-term success. Yet commercial teams often rely on data that arrive too late or lack the complete clinical context needed to understand what is driving trends. This makes it difficult to identify growth opportunities, address barriers, and adjust brand strategy while there is still time to influence adoption.
Truveta connects timely therapy adoption signals with detailed clinical context from daily updated, de-identified EHR data. Commercial teams can size clinically eligible populations before launch, inform launch strategy with insights available within days of encounters, and understand the factors shaping treatment decisions across patient populations and geographies with visibility into de-identified clinical notes.
Download the briefing to explore:
- How to size eligible populations and understand current care patterns before launch.
- How to track new therapy starts, dispensing, switching, and uptake within days of launch.
- How clinical data and notes help uncover why patients start, stop, switch, or remain on therapy.
- How to identify patient populations, specialties, and territories with untapped opportunity.
- How timely adoption insights can help focus brand, marketing, and field investments.
